Wnt signaling in colorectal cancer: pathogenic role and therapeutic target
H Zhao, T Ming, S Tang, S Ren, H Yang, M Liu, Q Tao… - Molecular cancer, 2022 - Springer
Abstract Background The Wnt signaling pathway is a complex network of protein interactions
that functions most commonly in embryonic development and cancer, but is also involved in …
that functions most commonly in embryonic development and cancer, but is also involved in …
Genetic mechanisms of fertilization failure and early embryonic arrest: a comprehensive review
Y Wei, J Wang, R Qu, W Zhang, Y Tan… - Human …, 2024 - academic.oup.com
BACKGROUND Infertility and pregnancy loss are longstanding problems. Successful
fertilization and high-quality embryos are prerequisites for an ongoing pregnancy. Studies …
fertilization and high-quality embryos are prerequisites for an ongoing pregnancy. Studies …
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
M Hashemi, S Abbaszadeh, M Rashidi, N Amini… - Environmental …, 2023 - Elsevier
Colorectal cancer (CRC) ranks as the third most aggressive tumor globally, and it can be
categorized into two forms: colitis-mediated CRC and sporadic CRC. The therapeutic …
categorized into two forms: colitis-mediated CRC and sporadic CRC. The therapeutic …
BZW2 inhibition reduces colorectal cancer growth and metastasis
Because survival of patients with metastatic colorectal cancer remain poor, there is an
urgent need to identify potential novel druggable targets that are associated with colorectal …
urgent need to identify potential novel druggable targets that are associated with colorectal …
Targeting TRIP13 for overcoming anticancer drug resistance
L Zhao, S Ye, S Jing, YJ Gao, T He - Oncology Reports, 2023 - spandidos-publications.com
Cancer is one of the greatest dangers to human wellbeing and survival. A key barrier to
effective cancer therapy is development of resistance to anti‑cancer medications. In cancer …
effective cancer therapy is development of resistance to anti‑cancer medications. In cancer …
MicroRNAs and colorectal cancer: clinical potential and regulatory networks
GY Osei, J Adu-Amankwaah, S Koomson… - Molecular Biology …, 2023 - Springer
Colorectal cancer (CRC) is a serious global health concern, with a high incidence and
mortality rate. Although there have been advancements in the early detection and treatment …
mortality rate. Although there have been advancements in the early detection and treatment …
Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms
R Li, Y Wu, Y Li, W Shuai, A Wang, Y Zhu, X Hu… - European Journal of …, 2023 - Elsevier
Colorectal cancer (CRC), a tumor of the digestive system, is characterized by high
malignancy and poor prognosis. Currently, targeted therapy of CRC is far away from …
malignancy and poor prognosis. Currently, targeted therapy of CRC is far away from …
[HTML][HTML] Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma
F Afaq, S Agarwal, P Bajpai, S Al Diffalha, HG Kim… - Neoplasia, 2024 - Elsevier
Thyroid hormone receptor-interacting protein 13 (TRIP13) is involved in cancer progression,
but its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. Thus, we assessed the …
but its role in pancreatic ductal adenocarcinoma (PDAC) is unknown. Thus, we assessed the …
TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy
L Liu, B Liao, R Fan, Y Liu, A Li, L Liu, Y Li, J Li - ACS Omega, 2024 - ACS Publications
Sulforaphane is one of the most characterized isothiocyanate compounds in cruciferous
vegetables and shows anticancer effects, especially antileukemia properties. However, the …
vegetables and shows anticancer effects, especially antileukemia properties. However, the …
Onco-Pathogen mediated cancer progression and associated signaling pathways in cancer development
S Kannampuzha, AV Gopalakrishnan, H Padinharayil… - Pathogens, 2023 - mdpi.com
Infection with viruses, bacteria, and parasites are thought to be the underlying cause of
about 8–17% of the world's cancer burden, ie, approximately one in every five malignancies …
about 8–17% of the world's cancer burden, ie, approximately one in every five malignancies …